






















![]()
TG Therapeutics, Inc. (TGTX) Q1 2026 Earnings Call May 6, 2026 8:30 AM EDT
Company Participants
Jenna Bosco - Senior Vice President of Corporate Communications
Michael Weiss - Chairman, CEO & President
Adam Waldman - Chief Commercialization Officer
Sean Power - CFO, Corporate Secretary & Treasurer
Conference Call Participants
Corinne Jenkins - Goldman Sachs Group, Inc., Research Division
Lut Ming Cheng - JPMorgan Chase & Co, Research Division
Gregory Wiessner - TD Cowen, Research Division
Cha Cha Yang - Jefferies LLC, Research Division
Michael DiFiore - Evercore ISI Institutional Equities, Research Division
Emily Bodnar - H.C. Wainwright & Co, LLC, Research Division
Jennifer Kim - Cantor Fitzgerald & Co., Research Division
William Wood - B. Riley Securities, Inc., Research Division
Presentation
Operator
Greetings, and welcome to the TG Therapeutics First Quarter Conference Call and Webcast. [Operator Instructions] As a reminder, this conference is being recorded. It is now my pleasure to introduce Jenna Bosco, Chief Communications Officer. Thank you. You may begin.
Jenna Bosco
Senior Vice President of Corporate Communications
Thank you. Welcome, everyone, and thank you for joining us this morning. I'm Jenna Bosco, and with me to discuss TG Therapeutics' First Quarter 2026 Financial results are Michael Weiss, our Chairman and Chief Executive Officer; Adam Waldman, our Chief Commercial Officer; and Sean Power, our Chief Financial Officer. Following our safe harbor statement, Mike will begin with an overview of our recent corporate developments. Adam will provide an update on our commercial efforts, and Sean will review our financial results before we open the call for Q&A.
Before we begin, I'd like to remind everyone that today's discussion will include forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These statements may include expectations regarding our future operating and financial performance, including sales trends, revenue guidance, projected milestones, development plans and outlook for our marketed products and our
此内容由惯性聚合(RSS阅读器)自动聚合整理,仅供阅读参考。 原文来自 — 版权归原作者所有。